Skip to main content
. 2020 May 26;9(14):5051–5064. doi: 10.1002/cam4.3096

FIGURE 2.

FIGURE 2

Kaplan‐Meier curves for progression free survival (PFS) and overall survival (OS) in 40 treated patients with pulmonary marginal zone lymphoma based on clinical features present at diagnosis. A, in all the patients; (B), by lactate dehydrogenase (LDH); (C), by B symptoms; (D), by stage (I‐II vs III‐IV); (E), by complete response (CR) after initial therapy; (F), by presence of extrapulmonary (Extrapulm) marginal zone lymphoma (MZL)